Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38
- PMID: 17991864
- DOI: 10.1126/science.1147379
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38
Abstract
The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)-dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.
Comment in
-
Cell signaling. mTOR, unleashed.Science. 2007 Nov 9;318(5852):926-7. doi: 10.1126/science.1150653. Science. 2007. PMID: 17991850 No abstract available.
Similar articles
-
The switch I region of Rheb is critical for its interaction with FKBP38.J Biol Chem. 2008 Sep 19;283(38):25963-70. doi: 10.1074/jbc.M802356200. Epub 2008 Jul 25. J Biol Chem. 2008. PMID: 18658153 Free PMC article.
-
Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.J Biol Chem. 2008 Nov 7;283(45):30482-92. doi: 10.1074/jbc.M803348200. Epub 2008 Aug 1. J Biol Chem. 2008. PMID: 18676370 Free PMC article.
-
Cell signaling. mTOR, unleashed.Science. 2007 Nov 9;318(5852):926-7. doi: 10.1126/science.1150653. Science. 2007. PMID: 17991850 No abstract available.
-
Amino acid regulation of TOR complex 1.Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E592-602. doi: 10.1152/ajpendo.90645.2008. Epub 2008 Sep 2. Am J Physiol Endocrinol Metab. 2009. PMID: 18765678 Free PMC article. Review.
-
Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin.Curr Opin Clin Nutr Metab Care. 2004 Jan;7(1):39-44. doi: 10.1097/00075197-200401000-00008. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15090902 Review.
Cited by
-
The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.J Neurochem. 2015 Apr;133(1):1-13. doi: 10.1111/jnc.13033. Epub 2015 Feb 24. J Neurochem. 2015. PMID: 25628064 Free PMC article. Review.
-
L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.Am J Cancer Res. 2015 Mar 15;5(4):1281-94. eCollection 2015. Am J Cancer Res. 2015. PMID: 26101697 Free PMC article. Review.
-
Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding.Tumour Biol. 2013 Aug;34(4):1991-2002. doi: 10.1007/s13277-013-0800-5. Epub 2013 Apr 30. Tumour Biol. 2013. PMID: 23625692 Review.
-
mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).PLoS One. 2015 Jun 4;10(6):e0126240. doi: 10.1371/journal.pone.0126240. eCollection 2015. PLoS One. 2015. PMID: 26042770 Free PMC article.
-
NT-3 promotes proprioceptive axon regeneration when combined with activation of the mTor intrinsic growth pathway but not with reduction of myelin extrinsic inhibitors.Exp Neurol. 2016 Sep;283(Pt A):73-84. doi: 10.1016/j.expneurol.2016.05.021. Epub 2016 Jun 2. Exp Neurol. 2016. PMID: 27264357 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous